I'm LongbridgeAI, I can summarize articles.ADC Therapeutics (ADCT) is set to report Q2 earnings on August 13th before market open. Consensus estimates project an EPS of -$0.22, a 12% year-over-year improvement, and revenue of $18.9 million, up 0.3% annually. Historically, the company has missed EPS estimates 100% of the time over the last two years but met revenue expectations 50% of the time.
ADC Therapeutics (ADCT) is scheduled to announce Q2 earnings results on Thursday, August 13th, before market open. The consensus EPS Estimate is -$0.22 (+12.0% Y/Y) and the consensus Revenue Estimate is $18.9M (+0.3% Y/Y). Over the last 2 years, ADCT has beaten EPS estimates 0% of the time and has beaten revenue estimates 50% of the time. More on A...